FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103985 [Registered on: 16/02/2026] Trial Registered Prospectively
Last Modified On: 16/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study on the effect of Gayatryadi Kashaya in Prediabetes 
Scientific Title of Study   A Clinical Study to evaluate the therapeutic effect of Gayatryadi Kashaya in Prediabetes 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tony Thomas Manamel 
Designation  Associate Professor 
Affiliation   
Address  Department of Kayachikitsa Sharada Ayurveda Medical College and Hospital, Devinagara, Talapady, Mangaluru

Dakshina Kannada
KARNATAKA
575023
India 
Phone  9035804963  
Fax    
Email  tonythomasmanamel@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Murali K 
Designation   
Affiliation   
Address  Centre of Textual Studies and Publications, Vaidyaratanam P.S. Variers Arya Vaidya Sala, Kottakkal

Malappuram
KERALA
676503
India 
Phone  9447141281  
Fax    
Email  muralivaidyaka@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tony Thomas Manamel 
Designation  Associate Professor 
Affiliation   
Address  Department of Kayachikitsa Sharada Ayurveda Medical College and Hospital, Devinagara, Talapady, Mangaluru

Dakshina Kannada
KARNATAKA
575023
India 
Phone  9035804963  
Fax    
Email  tonythomasmanamel@gmail.com  
 
Source of Monetary or Material Support  
Glocal University, Mirzapur, Saharanpur, Uttarpradesh 247121 
Sharada Ayurveda Medical College and Hospital, Devinagara, Talapady, Mangaluru, Karnataka 575023 
 
Primary Sponsor  
Name  Dr Tony Thomas Manamel 
Address  Sharada Ayurveda Medical College and Hospital, Devinagara, Talapady, Mangaluru, Karnataka 575023 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tony Thomas Manamel  Glocal College of Ayurvedic Medical Science and Research Center.  Department of Kayachikitsa, Mirzapur, Saharanpur, Uttar Pradesh-247121
Saharanpur
UTTAR PRADESH 
9035804963

tonythomasmanamel@gmail.com 
Dr Tony Thomas Manamel  Sharada Ayurveda Medical College and Hospital  Department of Kayachikitsa, Devinagara, Talapady, Mangaluru, Karnataka 575023
Dakshina Kannada
KARNATAKA 
9035804963

tonythomasmanamel@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Glocal University Institutional Ethics Committee  Approved 
Sharada Ayurveda Medical College Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gayatryadi Kashaya, Reference: Ashtanga Hridaya, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Honey 5 ml with Water 30 ml), Additional Information: Patients would be given a well-formed, printed chart given to the individuals indicating Pathya and Apathya.
2Comparator ArmLifestyle--Dinacarya: , Ritucarya: , Acara Rasayana:, Other:Honey 5ml with Water 30 ml, Pathya/Apathya:yes, Pathya:Yava, Methika, Kharjura, Godhuma, Nimba, Kamala, Shyamaka, Karavellaka, Utpala, Kodrava, Patola, Jangal Mamsa, Bajara, Rasona, Mudga, Udumbar, Purana Sura, Chanaka, Tala Phala, Sarsapa, Tikta Shaka, Ingudi, Goghrita, Apathya:Dugdha, Nava-Anna, Dadhi, Guda, Takra, Urada, Ikshuvikara, Gramya-Audaka Anoopa Mamsa, Pista-Anna, Madhur-Amla- Lavana Rasadi Aahara, Naveen Sura, Kapha-Meda Vardhak Aahara.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Patients fulfilling the diagnostic criteria.
2. Age group - between 18 years to 55 years.
3. Gender - Male and Female both will be included.
 
 
ExclusionCriteria 
Details  1. Diabetes Mellitus (Type-1&2).
2. Patients of age group less than 18 and more than 55 years.
3. Any associated Systemic disorder that will interfere with present treatment.
4. Patients associated with renal, cardiac, and other complication.
5. Pregnant and lactating women.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Fasting Blood Sugar Level, Postprandial Blood Sugar level and Urine Routine.  At Baseline, 4 weeks, 8 weeks, 12 weeks, and 16 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Fasting Lipid Profile & HbA1c.  At Baseline, & 16 weeks 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is a prospective, randomized, open-label, parallel arm interventional clinical study designed to evaluate the therapeutic effect of Gayatryadi Kashaya  in patients with prediabetes.

The study will be conducted in India over a total duration of 4 months, including a 3-month intervention period. A total of 120 patients will be enrolled and randomly allocated into two groups:

  1. Intervention group – receiving Gayatryadi Kashaya 15 mL twice daily added with 30 ml water, with Anupana of Honey 5ml before food.
  2. Control group – receiving Honey 5ml BD with 30 ml water before food.

Primary Outcome Measures:

  • Fasting Blood Sugar (FBS)
  • Postprandial Blood Sugar (PPBS)
  • Urine routine examination
These will be assessed on Day 0 (baseline), Day 30, Day 60, Day 90, and Day 120.

Secondary Outcome Measures:

  • Fasting lipid profile
  • HbA1c
These will be assessed on Day 0 (baseline) and Day 120.
 
Close